Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	38.19	61.67	44.63
Graham Fair Price	0.51	2.98	2.96
PEG	-5182.69	-25.94	-0.49
Price/Book	-6.63	1.17	1.26
Price/Cash Flow	-13.27	12.61	-14.54
Prices/Earnings	-4.62	14.41	15.11
Price/Sales	-11.19	2.32	2.62
Price/FCF	-13.27	12.61	-14.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	3.78	0.11	0.11
Operating Margin	-78.02	0.01	0.05
ROA	-5.00	< 0.005	< 0.005
ROE	0.02	0.02	-2.11
ROIC	0.02	< 0.005	-80.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	2.09	-0.63	232.13
Dividends QOQ	-0.15	99.43	65744.72
EBIT QOQ	5.46	-0.78	-85.78
EPS QOQ	-0.31	< 0.005	98.19
FCF QOQ	-3.62	2.04	-43.64
Revenue QOQ	-0.22	0.02	-93.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.43	35.65	0.61
Days Sales Outstanding (DSO)	124.13	84.46	-31.96
Inventory Turnover	2.54	2.52	-0.60
Debt/Capitalization	0.12	0.29	146.22
Quick Ratio	1.01	0.98	-2.79
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.33	5.34	23.35
Cash	0.79	1.79	126.38
Capex	-0.05	0.08	47.27
Free Cash Flow	-0.37	0.41	9.37
Revenue	2.08	2.22	6.81
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.23	1.18	-4.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.05	9.87	842.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating